[1] Jameson, J. L., Fauci, A. S., Kasper, D. L., Hauser, S. L., Longo, D. L., & Loscalzo, J. (Hrsg.). (2018). Harrison’s principles of internal medicine (20. Aufl.). McGraw-Hill Education.
[2] Hochberg, M. C., Gravallese, E. M., Silman, A. J., Smolen, J. S., Weinblatt, M. E., & Weisman, M. H. (Hrsg.). (2020). Rheumatology (7. Aufl.). Elsevier.
[3] Firestein, G. S., Budd, R. C., Gabriel, S. E., McInnes, I. B., & O’Dell, J. R. (Hrsg.). (2020). Kelley and Firestein’s textbook of rheumatology (11. Aufl.). Elsevier.
[4] Ralston, S. H., Penman, I. D., Strachan, M. W. J., & Hobson, R. P. (Hrsg.). (2022). Davidson's principles and practice of medicine (24. Aufl.). Elsevier.
[5] McGonagle, D. (2019). Orthopedic rheumatology: A comprehensive guide to inflammatory diseases of the musculoskeletal system. Springer.
[6] Gage, J., & Fountain, C. (Hrsg.). (2017). The Washington manual of rheumatology subspecialty consult (3. Aufl.). Wolters Kluwer.
[7] McInnes, I., & Tak, P. P. (Hrsg.). (2013). Oxford textbook of rheumatology (4. Aufl.). Oxford University Press.
[8] Cleland, J. A., Koppenhaver, S. L., & Netter, F. H. (2015). Netter's orthopedic clinical examination: An evidence-based approach (3. Aufl.). Elsevier.
[9] Hunder, G. G. (Hrsg.). (1997). Textbook of clinical rheumatology. Taylor & Francis.
[10]Yazici, Y., & Yazici, H. (2021). Musculoskeletal examination and joint injection techniques (2. Aufl.). Springer.
[11] Dijkshoorn B, Raadsen R, Nurmohamed MT. Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022. J Clin Med. 2022 May 11;11(10):2704. doi: 10.3390/jcm11102704. PMID: 35628831; PMCID: PMC9142998.
[12] Hansildaar R, Vedder D, Baniaamam M, Tausche AK, Gerritsen M, Nurmohamed MT. Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout. Lancet Rheumatol. 2021 Jan;3(1):e58-e70. doi: 10.1016/S2665-9913(20)30221-6. Epub 2020 Sep 1. PMID: 32904897; PMCID: PMC7462628.
[13] Manfredi, A., Cassone, G., Luppi, F., Atienza-Mateo, B., Cavazza, A., Sverzellati, N., … Sebastiani, M. (2021). Rheumatoid arthritis related interstitial lung disease. Expert Review of Clinical Immunology, 17(5), 485–497. DOI: 10.1080/1744666X.2021.1905524
[14] Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, Løkke A, Bendstrup E, Ellingsen T. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis. 2017 Oct;76(10):1700-1706. doi: 10.1136/annrheumdis-2017-211138. Epub 2017 Jun 13. PMID: 28611082.
[15] Kim H, Cho SK, Kim HW, Han J, Kim Y, Hwang KG, Sung YK. The Prevalence of Sjögren's Syndrome in Rheumatoid Arthritis Patients and Their Clinical Features. J Korean Med Sci. 2020 Nov 23;35(45):e369. DOI: 10.3346/jkms.2020.35.e369. PMID: 33230982; PMCID: PMC7683240.
[16] Haga HJ, Naderi Y, Moreno AM, Peen E. A study of the prevalence of sicca symptoms and secondary Sjögren's syndrome in patients with rheumatoid arthritis, and its association to disease activity and treatment profile. Int J Rheum Dis. 2012 Jun;15(3):284-8. doi: 10.1111/j.1756-185X.2012.01717.x. Epub 2012 Feb 13. PMID: 22709490.
[17] Diaz MJ, Natarelli N, Wei A, Rechdan M, Botto E, Tran JT, Forouzandeh M, Plaza JA, Kaffenberger BH. Cutaneous Manifestations of Rheumatoid Arthritis: Diagnosis and Treatment. J Pers Med. 2023 Oct 10;13(10):1479. doi: 10.3390/jpm13101479. PMID: 37888090; PMCID: PMC10608460.
[18] Moshayedi, S., Tasorian, B. & Almasi-Hashiani, A. The prevalence of osteoporosis in rheumatoid arthritis patient: a systematic review and meta-analysis. Sci Rep 12, 15844 (2022). DOI: 10.1038/s41598-022-20016-x[19] Hu Z, Zhang L, Lin Z, Zhao C, Xu S, Lin H, Zhang J, Li W, Chu Y. Prevalence and risk factors for bone loss in rheumatoid arthritis patients from South China: modeled by three methods. BMC Musculoskelet Disord. 2021 Jun 12;22(1):534. DOI: 10.1186/s12891-021-04403-5. PMID: 34118911; PMCID: PMC8199806.
[20] Guo, Q., Wang, Y., Xu, D. et al. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res 6, 15 (2018). DOI: 10.1038/s41413-018-0016-9